awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34763374-CF8950CC-1E47-4186-954B-BBDE2D139E45
Q34763374-CF8950CC-1E47-4186-954B-BBDE2D139E45
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34763374-CF8950CC-1E47-4186-954B-BBDE2D139E45
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial.
P2860
Q34763374-CF8950CC-1E47-4186-954B-BBDE2D139E45
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34763374-CF8950CC-1E47-4186-954B-BBDE2D139E45
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5a10bd58e585ce711306f1ae154eeeeed4aa8eb1
P2860
Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.